AIT Bioscience Ranks No. 179 on Inc. Magazine’s 2015 List of America’s Fastest-Growing Private Companies -AIT Bioscience

AIT Bioscience Ranks No. 179 on Inc. Magazine’s 2015 List of America’s Fastest-Growing Private Companies

Contact: Bo Kowalczyk
INDIANAPOLIS, September 30, 2015 – AIT Bioscience, LLC, ranked No. 179 on Inc. magazine’s 34th annual Inc. 500, an exclusive ranking of the nation’s fastest-growing private companies. The company ranked 16th overall in healthcare and is the highest ranked bioanalytical research laboratory on this year’s Inc. 500 list. The list represents the most comprehensive look at the most important segment of the economy-America’s independent entrepreneurs.
“Our growth over the past three years reflects the commitment of our staff and strong support from our customers, partners and board,” stated Terri Pascarelli, AIT Bioscience CEO. “Due to the growing need of biotechnology companies to investigate a wide range of novel therapeutic agents, we are seeing demand for our integrated bioanalytical research capabilities that utilize real-time quality control processes in Ligand Binding Assay (LBA) analytics for large molecules alongside LC-MS/MS analytics for small molecules in pre-clinical and phase I-III clinical trials.”
The company earned its ranking by achieving a remarkable three-year growth of more than 2,300 percent. The average company on the list achieved three-year growth of 490 percent. The top 500, featured in the September issue of Inc., is the most competitive crop in the list’s history.
About AIT Bioscience, LLC
AIT Bioscience, LLC, headquartered in Indianapolis, Indiana, is an integrated contract research laboratory (CRO) supported by a state-of-the-art, smart, electronic laboratory environment. This allows AIT Bioscience to devise the best solution for its clients, across each of its bioanalytical service areas. AIT Bioscience delivers robust analytical methods, highly-skilled and experienced client consultation, efficient sample logistics and rapid sample analysis from pre-IND through investigational new drug (IND), new drug application (NDA), abbreviated new drug application (ANDA) and Biologics License Application (BLA). For more information, visit